Tweet
I first perform genome analysis, and predict many genes. I don't know how to perform Go analysis. I have try the blast2go on the net service, however it is very slowly. Can I used other located software to complete this task? look forward your help.
-
-
You definitely need to be more specific about your experiment, what you have done and what you want to do. Questions like these never lead to good answers. 'Genome analysis' is what?--------------
Ethan -
Thank you for your suggest. I have construct a draft map for an eukaryotic animal. By the gene predict software, like exonhunter, I have received nearly 11000 genes among this whole genome. Now, I want to use these fasta sequences (predict genes) to receive corresponding Go annotation. I have tried the blast2go on the net service, however it is very slowly. It will spend 2 weeks in annoting 11000 genes. Do you know some more efficient software can complete this task?Last edited by henry_by; 04-08-2012, 12:48 AM.Comment
-
Hi henry_by,
If I'm not mistaken, EBI has GO annotations embedded in some fasta headers. You may want to look into creating a local blast-instance of these files and locally-blast your predicted genes against it. You can then simply parse such hits and extract out the respective GO from the header... shouldn't take very long for your 11k genes.Comment
-
You could try InterProScan, which will allow you to annotate your genes, and it will return GO terms with your annotations.Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment